New Providence Acquisition Corp. (NASDAQ:NPA) announced that its shareholders approved its business combination with space-based broadband provider AST & Science at a special meeting earlier today.
The parties expect to close the deal by about April 6, after which the combined company will operate as AST SpaceMobile with its shares and warrants trading on the Nasdaq under the symbols “ASTS” and “ASTSW”, respectively.
New Providence noted in its press release that AST expects to receive $462 million in proceeds after the vote, and while it did not share redemption figures, this number indicates they were minimal as this is the roughly sum of its PIPE and estimated trust value pre-redemptions
The two sides initially announced their $1.4 billion business combination on December 11. Midland, Texas-based AST is working to build the first space-based cellular broadband network to fill coverage gaps and eventually make 4G and 5G access universal.
ADVISORS
- Barclays is acting as financial advisor and capital markets advisor to AST SpaceMobile.
- Barclays and Deutsche Bank Securities Inc. acted as placement agents to New Providence in connection with the PIPE offering.
- Deutsche Bank Securities Inc. and BTIG LLC are acting as financial and capital markets advisors to New Providence.
- Latham & Watkins LLP and Foley & Lardner LLP are acting as legal counsel to AST SpaceMobile.
- Kirkland & Ellis LLP is acting as legal counsel to New Providence.
At the SPAC of Dawn Investors are set to get an update on Core CPI inflation readings this morning as de-SPACs continue to report on operational advances alongside their first quarter earnings. Among them, eVTOL developer Archer (NYSE:ACHR) noted that it is on track to deliver its first Midnight aircraft to the UAE in the...
Perimeter Acquisition Corp. I (NASDAQ:PMTRU) announced the pricing of its upsized $210 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “PMTRU”, Tuesday, May 13, 2025. The new SPAC aims to combine with a target company with that can contribute to the re-industrialization of the United States economy,...
Horizon Space II (NASDAQ:HSPT) has signed a definitive agreement to combine with clinical stage biotech firm SL Bio Ltd. for $5.57 billion in equity consideration. Taipei, Taiwan-based SL Bio is developing drug candidates to treat several cancer types while also selling over-the-counter beauty products derived from natural extracts. The combined company is expected to trade...
At the SPAC of Dawn This is set to be a slower week for votes with just two SPACs seeking an extension and none yet scheduling a meeting for approving a business combination. Integrated Rail & Resources (OTC:IRRX) primed the pump somewhat for investors ahead of its Tuesday special meeting by announcing it has entered...
Terms Tracker for the Week Ending May 9, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. After the sprint that was last week, with nine IPOs and six new SPAC filings, this week took a breather. Only two SPACs priced, there...